Renin-angiotensin-aldosterone system (RAAS) inhibitor, Zofenopril calcium, Purity ≥98%

PRODUCTS

Online Inquiry

Cat. No.: X24-09-YM632

Renin-angiotensin-aldosterone system (RAAS) inhibitor, Zofenopril calcium, Purity ≥98%

Synonym: 81938-43-4; Zofenopril calcium salt; Zoprace; Calcium; (2S,4S)-1-[(2S)-3-benzoylsulfanyl-2-methylpropanoyl]-4-phenylsulfanylpyrrolidine-2-carboxylate; Renin-angiotensin-aldosterone system (RAAS) inhibitor

MDL: MFCD08704648
CAS Number: 81938-43-4
Compound CID: 3033690

Product Size

10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Zofenopril calcium, soluble in DMSO and insoluble in water and ethanol, is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of angiotensin-converting enzyme (ACE) by inhibiting endocrinology-hormones. The molecular weight of the compound is 897.17, and its molecular formula is 2(C₂₂H₂₂NO₄S₂)·Ca.

Molecular Weight

897.17

Molecular Formula

2(C₂₂H₂₂NO₄S₂)·Ca

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Solubility

In vitro: DMSO (warmed): 5 mg/mL (5.57 mM); Water: insoluble; Ethanol: insoluble

Identity

Confirmed by NMR/HPLC/MS.

Applications

Zofenopril calcium displays the significant potential to act as an effective ACE inhibitor that blocks the production of angiotensin II, promoting vasodilation and lowering blood pressure.